The Global Opioid Use Disorder Treatment Market Demand is predicted to increase at a CAGR of 10.5% during the forecast period, with an estimated value of US$ 3.07 billion in 2023 and US$ 8.4 billion by 2033. To increase their customer base, drug misuse treatment providers and manufacturers use various media such as television advertising, newspapers, and information pamphlets to raise awareness about the destructive effects of drug abuse and the significance of getting treatment.
Unlock growth potential with industry expertise. Download your market sample report now: https://www.futuremarketinsights.com/reports/sample/rep-gb-16561
Opioid Use Disorder (OUD) is a serious medical condition characterized by a compulsive pattern of opioid use despite harmful consequences. Fortunately, there are effective treatments available to help individuals recover from OUD and regain control over their lives. One of the most common and evidence-based approaches to OUD treatment is medication-assisted treatment (MAT). MAT combines the use of medications, such as methadone, buprenorphine, or naltrexone, with counseling and behavioral therapies to provide a comprehensive approach to recovery. These medications help reduce cravings and withdrawal symptoms, allowing individuals to stabilize their lives, engage in treatment, and work towards long-term recovery. MAT has been shown to significantly improve treatment outcomes, reduce illicit opioid use, lower the risk of overdose, and improve overall quality of life for individuals with OUD.
Opioid Use Disorder Treatment Market Key Takeaways:
- North America is predicted to dominate the industry by the end of the forecast period, with a market share of over 48%.
- Throughout the forecast period, the East Asian market is expected to grow at the quickest rate of 8.8%.
- Buprenorphine is expected to account for 81.4% of the market by the end of the forecast period.
- Hospitals are predicted to dominate the market by distribution channel, accounting for 35% of the market by 2033.
“Rising collaborations and mergers between companies, increasing research and development activities and adoption of technological advanced techniques for treating Opioid disorder will drive the industry’s growth,” comments an FMI analyst
Ask More About This Market’s Geographical Distribution Along With a Detailed Analysis of the Top Regions: https://www.futuremarketinsights.com/ask-question/rep-gb-16561
Opioid Use Disorder Treatment Market Competitive Landscape:
The Opioid use disorder treatment Market is competitive and consists of several major players. Major players are creating novel delivery systems for the treatment of opioid use disorder. This is expected to propel Opioid use disorder treatment market. The major players in the market are: Trevena, Opiate Pharmaceutical, Aphios, Kyowa kirin, Gamida-Cell, Novartis, Titan Pharmaceuticals, Inc., Hikma Pharmaceuticals, MediciNova, Alkermes, Inc., BioDelivery Sciences International, Inc.
Some recent developments in the Opioid Use Disorder Treatment Market are:
- In January 2022, Trevena, Inc. declared that China’s National Medical Products Administration (NMPA) has accepted the submission of a New Drug Application (NDA) for OLINVYK (oliceridine) injection, a novel IV analgesic that has been approved in the United States by the FDA for use in adults for managing acute pain severe enough to require an intravenous opioid analgesic.
- In October 2021, Esteve Pharmaceuticals received authorisation from the United States Food and Drug Administration (FDA) for SEGLENTIS (celecoxib and tramadol hydrochloride) for the management of acute pain in adults that is extreme enough to require an opioid analgesic.
- In January 2020, Titan Pharmaceuticals, Inc. made a revelation that they had entered into an agreement with AllianceRx Walgreens Prime for the expansion of accessibility of patients for Titan’s opioid use disorder implant branded as “Probuphine implant”.
More Valuable Insights Available:
North America is the largest Opioid Use Disorder market. The region has the highest prevalence of opioid addiction in the world, which has led to an increase in the demand for opioid use disorder treatments. The United States is the largest market in the region, accounting for a significant share of the market.
Purchase Now to Access Segment-specific Information, Uncover Key Trends, Drivers, and Challenges: https://www.futuremarketinsights.com/checkout/16561
Key Segments Profiled in the Opioid Use Disorder Treatment Market Survey:
By Drug Type:
- Romiplostim
- Omidubicel
- Nalmefene
- Buprenorfine
- Methadone
- Naltrexone
By Route of Administration:
- Oral
- Parenteral
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
